Data Foundry

Medical device recalls 2020

QIAstat-Dx Respiratory SARS-CoV-2 Panel REF 691223 — Class II medical device recall Z-2938-2020

Terminated recall by Qiagen Sciences LLC, reported 2020-09-16, distributed nationwide. There is an increased rate of potential false positive results for the Influenza A (no subtype) target, which

Recall numberZ-2938-2020
Product typeMedical device
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmQiagen Sciences LLC, Germantown, MD, United States
Recall initiated2020-07-15
Classified2020-09-04
Reported by FDA2020-09-16
Terminated2021-03-22
DistributedNationwide (US)
Quantity1,474 kits
Lot numbers166020729, 166022794, 166023368, 166023399, 166023400, 166024163, 166024165, 166024166, 166025078, 166025888, 166025889, 166028721, 166028722, 166029506, 166029508
Model numbers691223

Product

QIAstat-Dx Respiratory SARS-CoV-2 Panel REF 691223 (US IVD under FDA EUA) - Product Usage: intended for the qualitative detection and differentiation of nucleic acid from multiple respiratory viral and bacterial organisms, including the SARS-CoV-2 virus, in nasopharyngeal swabs (NPS) eluted in universal transport media collected from patients suspected of COVID-19 by their healthcare provider.

Reason for recall

There is an increased rate of potential false positive results for the Influenza A (no subtype) target, which may lead to 1) inappropriate antiviral use, 2) erroneous or delayed differential diagnosis and missing of an alternative diagnosis.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-2938-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.